SOURCE: SOHM, Inc.

February 15, 2011 09:00 ET

SOHM Reports Record 2010 Year End With Revenue Growth Increasing 249 Percent

Growth Fueled by Sharp Increase in Demand for SOHM's Private Label Generic Pharmaceuticals, Strong Uptake of New Products, Expansion of Geographic Target Markets and Addition of Strategic Partners

BUENA PARK, CA--(Marketwire - February 15, 2011) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that it reported a record year end and posted a 249 percent year-over-year increase in revenue for the year ended December 31, 2010. Growth was fueled by a sharp increase in demand for the Company's private label generic pharmaceuticals, strong uptake of new product offerings, expansion of geographic target markets, and addition of strategic partners. Revenue for the year ended December 31, 2010 increased 249% to $781,675 compared to $194,904 for the year ended December 31, 2009.

"2010 was an outstanding year by all accounts," stated Shailesh Shah, President and CEO of SOHM, Inc. "With that said the real opportunity lies ahead, as more and more global emerging markets look to accelerate use of generic drugs and nutritional supplements to supply the health care requirements of their growing populations. Our entire team at SOHM is driven to provide high quality pharmaceutical products to the millions of consumers that currently have little or no access to affordable generic drugs."

About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact